explore -WSS

explore

author：focus 2025-10-01 02:12:33 - browse：2184

illustration of a colorful DNA strand, partly broken into pieces. -- health coverage from STAT — Adobe

BALTIMORE — An ambitious effort to cure HIV with CRISPR genome editing fell short in an early clinical trial, investigators announced Friday morning.

In the study, run by Excision BioTherapeutics, researchers tried to use the gene editing tool to address a chief reason HIV has been so hard to cure. While antiviral drugs can clear patients of replicating virus, HIV is able to worm its way into a patients’ own DNA in certain cells. If the patient ever stops taking medicines, those cells start pumping out HIV particles and the infection roars back.

Researchers hoped they could send CRISPR to those cells and, by cutting the HIV DNA lurking there at two spots, slice out the virus. In the Phase 1 trial, investigators administered the treatment to five patients. They then took three of them off conventional antiviral treatment.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： With Roe v Wade overturned, abortion providers work to adapt

WSS

IVG is promising — but it won’t replace IVF quite yet

Flu, Covid vaccination rates decline, new survey data show

6 solutions to address cancer drug shortages and others

Greece's new parliament sworn in following conservative party's election victory

ThunderShirts, dance parties and anxiety meds can help ease dogs' July Fourth dread

Lawsuit highlights wrinkle for disputes over surprise medical bills

focus

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

explore

Medicare proposal to cover medical devices draws a mixed reaction

Noem? Reynolds? A very early look at the Republican 'veepstakes'

Malaria cases in Florida and Texas: Here’s what you need to know

Michigan man accused of striking an officer during the US Capitol attack is arrested in Florida

Moonlake's readout produced a cash windfall. Risks remain

Noem? Reynolds? A very early look at the Republican 'veepstakes'

Supreme Court strikes down use of affirmative action

Lawsuit highlights wrinkle for disputes over surprise medical bills

Anesthesiologist group: stop taking Ozempic before surgery

Masked assailants attack a journalist and a lawyer in Russia's Chechnya province

entertainment

Medicare innovation center doesn’t save money, experts say

Brazil's Neymar fined $3.3 million for illegal artificial lake at mansion outside Rio

Brazil's Neymar fined $3.3 million for illegal artificial lake at mansion outside Rio

Palestinian attacker wounds 8 in Tel Aviv as Israel presses on with West Bank operation

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

Michigan man accused of striking an officer during the US Capitol attack is arrested in Florida

focus

focus

focus

Wikipedia